From ME Research UK.
In May, a Bill was introduced into the US Congress (H.R. 5057) by Representative Jaime Raskin calling for “the expansion, intensification, and coordination of the programs and activities of the National Institutes of Health with respect to post-viral chronic neuroimmune diseases, specifically myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), to support the COVID–19 response, and for other purposes.” The Bill, the first, specific Congressional legislation on ME/CFS, has been remitted to the Committee on Energy and Commerce.
If passed, an additional $60 million would be allocated to existing ME/CFS research projects and into researching connections between ME/CFS and COVID-19 survivors over a 4 year period to 2024.
To read the rest of this story, click on the link below: